# Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
Canonical URL: https://biopharmsignal.com/news/SEER/seer-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-full-year-2026-outlook
Ticker: SEER
Company: Seer, Inc
Source: Seer, Inc
Published: 2026-02-26 21:05 EST
Original Source URL: https://investor.seer.bio
## Summary

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights Generated revenue of $4.2

## Article Body
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights Generated revenue of $4.2
## Recent Company News
- 2026-07-20 11:00 EST — [Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY](https://biopharmsignal.com/news/SEER/seer-urges-stockholders-to-vote-for-seer-s-highly-qualified-director-nominees-on-6787833a) — Source: Seer, Inc
- 2026-07-20 10:00 EST — [Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.](https://biopharmsignal.com/news/SEER/special-committee-of-seer-s-board-of-directors-unanimously-rejects-unsolicited-a-61f31e25) — Source: Seer, Inc
- 2026-07-14 20:05 EST — [Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight](https://biopharmsignal.com/news/SEER/seer-board-of-directors-issues-letter-to-shareholders-setting-the-record-straigh-cbf9fae4) — Source: Seer, Inc
- 2026-07-08 11:00 EST — [Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees](https://biopharmsignal.com/news/SEER/seer-board-of-directors-issues-letter-to-shareholders-demonstrating-the-strength-2fe1284b) — Source: Seer, Inc
- 2026-07-06 11:00 EST — [Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential](https://biopharmsignal.com/news/SEER/seer-files-investor-presentation-highlighting-strong-momentum-commercial-opportu-e67fff29) — Source: Seer, Inc
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)